US President Donald Trump hints that there if India doesn’t allow export of anti-malarial Hydroxychloroquine tablets used to fight corona infection to the US, there may be retaliation.
He also brought the US long-running grievances with India on trade issues into the light. A joint step taken by the two countries to bridge the gap between them in times of emergencies got failed in February, Trump’s first visit to India.
The US government placed the order for Hydroxychloroquine tablets in March through an agency taking care of medical supplies and equipment needed to deal with the corona pandemic.
The White House has declared Hydroxychloroquine tablets as an effective medicine in the treatment for COVID-19. However, the health experts of the US have officially approved the medication only for treating malaria, rheumatoid arthritis, and lupus.
The Food and Drug Administration of the US also warned the citizens against the use of Hydroxychloroquine tablets as a potential medicine for COVID-19. It recommended wearing a cloth face-covering in public and should be washed regularly. Wash hands and face immediately after removing the covering.